Identifying functional genetic variants in DNA repair pathway using protein conservation analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 5, 2004, Pages 801-807

  Savas, Sevtap ^a,b   Kim, David Y ^a   Ahmad, M Farhan ^a   Shariff, Mehjabeen ^a   Ozcelik, Hilmi ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; DNA REPAIR PROTEIN; GENE PRODUCT; GLUTAMINE; HISTIDINE; METHIONINE; PROTEIN XRCC1; PROTEIN XRCC3; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA REPAIR; DNA REPAIR GENE; ENVIRONMENTAL FACTOR; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HEREDITY; HUMAN; HUMAN GENOME; NON SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISM; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONSERVATION ANALYSIS; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROTEIN CONFORMATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VARIATION (GENETICS);

EID: 2942604293     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair/proapoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002;511:145-78.
2. Rouse J, Jackson SP. Interfaces between the detection signaling and repair of DNA damage. Science 2002;297:547-51.
3. Mohrenweiser HW, Wilson DM III, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003;526:93-125.
4. Daly AK, Day CP. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001;52:489-99.
5. Miller RD, Kwok P-Y. The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum Mol Genet 2001;10:2195-8.
6. Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol Med 2001;7:507-12.
7. Gray IC, Campbell DA, Spurr NK. Single nucleotide polymorphisms as tools in human genetics. Hum Mol Genet 2000;9:2403-8.
8. Shastry BK. SNP alleles in human disease and evolution. J Hum Genet 2002;47:561-6.
9. Chasman D, Adams RM. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol 2001;307:683-706.
10. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863-74.
11. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002;12:436-46.
12. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001;10:591-7.
13. Wang Z, Moult J. SNPs, protein structure, and disease. Hum Mutat 2001;17:263-70.
14. Ferrer-Costa C, Orozco M, de la Cruz X. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J Mol Biol 2002;315:771-86.
15. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002;30:3894-900.
16. Clifford R, Edmonson M, Hu Y, Nguyen C, Scherpbier T, Buetow KH. Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project. Genome Res 2000;10:1259-65.
17. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29:308-11.
18. Fredman D, Siegfried M, Yuan YP, Bork P, Lehvaslaiho H, Brookes AJ. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res 2002;230:387-91.
19. Wheeler DL, Church DM, Lash AE, et al. Database resources of the National Center for Biotechnology Information: 2002 update. Nucleic Acids Res 2002;30:13-6.
20. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomark Prev 2002;11(10 Pt 1):1054-64.
21. O'Donovan C, Martin MJ, Gattiker A, Gasteiger E, Bairoch A, Apweiler R. High-quality protein knowledge resource: SWISS-PROT and TrEMBL. Brief Bioinform 2002;3:275-84.
22. Pagano M, Gauvreau K. Principles of biostatistics. 2nd ed. Pacific Grove, CA: Duxbury; 2000. p. 342-6.
23. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-8.
24. Gu Z, Hillier L, Kwok PY. Single nucleotide polymorphism hunting in cyberspace. Hum Mutat 1998;12:221-5.
25. Cox DG, Boillot C, Canzian F. Data mining: efficiency of using sequence databases for polymorphism discovery. Hum Mutat 2001;17:141-50.
26. Lercher MJ, Hurst LD. Human SNP variability and mutation rate are higher in regions of high recombination. Trends Genet 2002;18:337-340.
27. Grohmann K, Schuelke M, Diers A, et al. Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 2001;29:75-7.
28. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomark Prev 2001;10:217-22.
29. Kim SU, Park SK, Yoo KY, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 2002;12:335-8.
30. Divine KK, Gilliland FD, Crowell RE, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 2001;461:273-8.
31. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11:1399-407.
32. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
33. Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000;60:5612-6.
34. Cho EY, Hildesheim A, Chen CJ, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomark Prev 2003;12:1100-4.
35. van Gils CH, Bostick RM, Stern MC, Taylor JA. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomark Prev 2002;11:1279-84.
36. Ratnasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomark Prev 2001;10:119-23.
37. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002;23:1003-8.
38. Graur D, Li W-H. Dynamics of genes in populations. Fundamentals of molecular evolution. 2nd ed. Sunderland, MA: Sinaur Associates, Inc; 2000. p. 41.
39. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002;3:263-92.
40. Martin NMB. DNA repair inhibition and cancer therapy. J Photochem Photobiol 2001;63:162-70.